Physician profile
Jonathan E Mcneal
NPI 1164670345
$6,889.18
in general payments reported to CMS, 2019-2025
13 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.36 · 2020: $162 · 2021: $50.08 · 2022: $136 · 2023: $6,001 · 2024: $277 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,978 · Food and Beverage: $805 · Travel and Lodging: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,977.76 |
| Food and Beverage | $804.60 |
| Travel and Lodging | $677.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $6,030.59 | 2019-2024 | Senza |
| Medtronic, INC. | $174.57 | 2022-2024 | Mazor X System, Graftonand Grafton Plusdemineralized Bone Matrix (Dbm), Strata |
| Boston Scientific Corporation | $139.90 | 2020-2025 | General - Therapies |
| Kuros Biosciences USA, INC | $105.15 | 2023-2024 | Magnetos |
| Abbott Laboratories | $85.71 | 2023-2025 | Penta, Proclaim, Eterna |
| Depuy Synthes Sales INC. | $83.67 | 2020-2021 | |
| Providence Medical Technology, INC. | $80.26 | 2025 | |
| Ossur Americas, INC. | $42.34 | 2025 | |
| Orthofix Medical, INC. | $40.69 | 2019-2025 | Spinal-Stim |
| Ucb, INC. | $36.17 | 2024 | Fintepla |
| Stryker Corporation | $31.07 | 2023 | Na, Core |
| Ethicon US, LLC | $21.18 | 2023 | Stratafix, Dermabond |
| Astrazeneca Pharmaceuticals LP | $17.88 | 2024 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Mcneal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.